Alex Maly - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Alex Maly

Showing results (11-20 of 13) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 13 results.

Dermatologic Therapy|October 3, 2022

Dermatological adverse events under programmed cell death-1 inhibitors as a prognostic marker in metastatic melanomaRony Shreberk-Hassidim, Lilach Aizenbud, Shalev Lussheimer, et al.

Journal of the American Academy of Dermatology|May 19, 2015

Generalized verrucosis and HPV-3 susceptibility associated with CD4 T-cell lymphopenia caused by inherited human interleukin-7 deficiencyLiran Horev, Susanne Unger, Vered Molho-Pessach, et al.

The Journal of Investigative Dermatology|December 31, 2005

Involvement of the CXCL12/CXCR4 pathway in the recovery of skin following burnsShani Avniel, Zaretski Arik, Alex Maly, et al.

Pageof 2

Search research articles

Showing results (11-20 of 13) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 13 results.

Dermatologic Therapy|October 3, 2022

Dermatological adverse events under programmed cell death-1 inhibitors as a prognostic marker in metastatic melanomaRony Shreberk-Hassidim, Lilach Aizenbud, Shalev Lussheimer, et al.

Journal of the American Academy of Dermatology|May 19, 2015

Generalized verrucosis and HPV-3 susceptibility associated with CD4 T-cell lymphopenia caused by inherited human interleukin-7 deficiencyLiran Horev, Susanne Unger, Vered Molho-Pessach, et al.

The Journal of Investigative Dermatology|December 31, 2005

Involvement of the CXCL12/CXCR4 pathway in the recovery of skin following burnsShani Avniel, Zaretski Arik, Alex Maly, et al.

Pageof 2